Day One Biopharmaceuticals, Inc. (DAWN): Price and Financial Metrics

Day One Biopharmaceuticals, Inc. (DAWN): $7.78

0.10 (+1.30%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add DAWN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#107 of 306

in industry

DAWN Price/Volume Stats

Current price $7.78 52-week high $18.07
Prev. close $7.68 52-week low $6.41
Day low $7.46 Volume 1,289,444
Day high $7.81 Avg. volume 1,172,090
50-day MA $8.40 Dividend yield N/A
200-day MA $12.38 Market Cap 788.53M

DAWN Stock Price Chart Interactive Chart >


Day One Biopharmaceuticals, Inc. (DAWN) Company Bio


Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


DAWN Latest News Stream


Event/Time News Detail
Loading, please wait...

DAWN Latest Social Stream


Loading social stream, please wait...

View Full DAWN Social Stream

DAWN Price Returns

1-mo -1.89%
3-mo -39.50%
6-mo -46.89%
1-year -54.50%
3-year -8.69%
5-year N/A
YTD -38.60%
2024 -13.22%
2023 -32.16%
2022 27.72%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!